Phase I Dose Finding and Proof-of-concept Study of Panobinostat With Standard Dose Cytarabine and Daunorubicin for Untreated Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome
Sponsors and Collaborators
C. Babis Andreadis
University of California, San Francisco
Novartis
Novartis
Contact
Paula Fiermonte
415-885-7605
Glenna Auerback
415-476-9608
Investigator
Charalambos Andreadis, M.D.
University of California, San Francisco
ClinicalTrials.gov Identifier
